Synthesis, quality control and in vivo evaluation of [123I] rhTIMP-2, a potential tumour-imaging agent

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 48, Issue 5, 2005, Pages 387-396

  Oltenfreiter, Ruth ^a,c   Burvenich, Ingrid ^a   Staelens, Ludovicus ^a   Lejeune, Annabelle ^b   Frankenne, Francis ^b   Foidart, Jean Michel ^b   Slegers, Guido ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c Faculty of Pharmaceutical Sciences   (Belgium)

Author keywords

In vivo biodistribution; Iodine 123; Radiolabelled rhTIMP 2; SPECT; Tumour imaging

Indexed keywords

DIAGNOSIS; IODINE; QUALITY CONTROL; TRICHLOROACETIC ACID;

IN VIVO BIODISTRIBUTION; IN-VIVO; IODINE-123; MATRIX; METALLOPROTEINASES; RADIOLABELED RHTIMP-2; SPECT; TUMOR IMAGING; TUMOR IMAGING AGENTS; VIVO BIODISTRIBUTION;

TUMORS;

GELATINASE B; IODINE 123; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; RECOMBINANT HUMAN TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CHO CELL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG LABELING; DRUG PURITY; DRUG STABILITY; DRUG SYNTHESIS; EXTRACELLULAR MATRIX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; QUALITY CONTROL; QUANTUM YIELD; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR SCINTISCANNING;

EID: 17844377590     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlcr.937     Document Type: Article

References (16)

1. Egeblad M, Werb Z. Nat Rev Cancer 2002; 2: 161-174.
2. McCawley LJ, Matrisian LM. Mol Med Today 2000; 6: 149-156.
3. Maquoi E, Peyrollier K, Noël A, Foidart JM, Frankenne F. Biochem J 2003; 373: 19-24.
4. Seiki M. Acta Pathol Microbiol Immunol Scand 1999; 107: 137-143.
5. Toth M, Bernardo MM, Gervasi DC, Soloway PD, Wang Z, Bigg HF, Overall CM, DeClerck YA, Tschesche H, Cher ML, Brown S, Mobashery S, Fridman R. J Biol Chem 2000; 275(52): 41415-41423.
6. Sato T, Iwai M, Sakai T, Sato H, Seiki M, Mori Y, Ito A. Br J Cancer 1999; 80(8): 1137-1143.
7. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP, Murphy G. J Biol Chem 1998; 273(2): 871-880.
8. Bernardo MM, Fridman R. Biochem J 2003; 374: 739-745.
9. Uekita T, Itoh Y, Yana I, Ohno H, Seiki M. J Cell Biol 2001; 155: 1345-1356.
10. De Clerck YA, Yean TD, Chan D, Shimada H, Langley KE. Cancer Res 1991; 51: 2151-2157.
11. Noël A, Santavicca M, Stoll I, L'Hoir C, Staub A, Murphy G, Rio MC, Basset P. J Biol Chem 1995; 270(22): 866-872.
12. Haisma HJ, Hilgers J, Zurawski Jr VR. J Nucl Med 1986; 27: 1890-1895.
13. Hajitou A, Baramova EN, Bajou K, Noe V, Bruyneel E, Marcel M, Collette J, Foidart JM, Calberg-Bacq CM. Oncogene 1998; 17(16): 2059-2071.
14. Goffin F, Munaut C, Frankenne F, d'Hauterive SP, Béliard A, Fridman V, Nervo P, Colige A, Foidart JM. Biol Reprod 2003; 69(3): 976-984.
15. Lahorte C, Dumont F, Slegers G, Van de Wiele C, Dierckx RA. Nucl Med Commun 1999; 20(10): 948-949.
16. Hajitou A, Sounni NE, Devy L, Grignet-Debrus C, Lewalle JM, Li H, Deroanne CF, Lu H, Colige A, Nusgens BV, Frankenne F, Maron A, Yeh P, Perricaudet M, Chang Y, Soria C, Calberg-Bacq CM, Foidart JM, Noel A. Cancer Res 2001; 61(8): 3450-3457.